Literature DB >> 21438872

Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.

R Freguja1, K Gianesin, I Mosconi, M Zanchetta, F Carmona, O Rampon, C Giaquinto, A De Rossi.   

Abstract

The function of CD4(+) T cells with regulatory activity (T(regs)) is the down-regulation of immune responses. This suppressive activity may limit the magnitude of effector responses, resulting in failure to control human immunodeficiency virus 1 (HIV-1) infection, but may also suppress chronic immune activation, a characteristic feature of HIV-1 disease. We evaluated the correlation between viral load, immune activation and T(regs) in HIV-1-infected children. Eighty-nine HIV-1-infected children (aged 6-14 years) were included in the study and analysed for HIV-1 plasmaviraemia, HIV-1 DNA load, CD4 and CD8 cell subsets. T(reg) cells [CD4(+)CD25(high)CD127(low) forkhead box P3 (FoxP3(high))] and CD8-activated T cells (CD8(+)CD38(+)) were determined by flow cytometry. Results showed that the number of activated CD8(+)CD38(+)T cells increased in relation to HIV-1 RNA plasmaviraemia (r = 0·403, P < 0·0001). The proportion of T(regs) also correlated positively with HIV-1 plasmaviraemia (r = 0·323, P = 0·002), but correlated inversely with CD4(+) cells (r = -0·312, P = 0·004), thus suggesting a selective expansion along with increased viraemia and CD4(+) depletion. Interestingly, a positive correlation was found between the levels of T(regs) and CD8(+)CD38(+)T cells (r = 0·305, P = 0·005), and the percentage of T(regs) tended to correlate with HIV-1 DNA load (r = 0·224, P = 0·062). Overall, these findings suggest that immune activation contributes to the expansion of T(reg) cells. In turn, the suppressive activity of T(regs) may impair effector responses against HIV-1, but appears to be ineffective in limiting immune activation.
© 2011 The Authors; Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438872      PMCID: PMC3087933          DOI: 10.1111/j.1365-2249.2011.04383.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.

Authors:  Anita De Rossi; A Sarah Walker; Davide De Forni; Diana M Gibb
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

3.  Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus.

Authors:  S Chavan; B Bennuri; M Kharbanda; A Chandrasekaran; S Bakshi; S Pahwa
Journal:  J Infect Dis       Date:  2001-04-13       Impact factor: 5.226

4.  Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness.

Authors:  Lucia Ometto; Davide De Forni; Fiorulla Patiri; Virginie Trouplin; Fabrizio Mammano; Vania Giacomet; Carlo Giaquinto; Daniel Douek; Richard Koup; Anita De Rossi
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.

Authors:  J C Gaardbo; S D Nielsen; S J Vedel; A K Ersbøll; L Harritshøj; L P Ryder; J O Nielsen; L Kolte
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

8.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

9.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.

Authors:  Anita De Rossi; A Sarah Walker; Nigel Klein; Davide De Forni; Doug King; Diana M Gibb
Journal:  J Infect Dis       Date:  2002-07-05       Impact factor: 5.226

10.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

View more
  17 in total

1.  Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV.

Authors:  Theresa L Whiteside
Journal:  Cancer Microenviron       Date:  2014-11-12

2.  Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV.

Authors:  G Degaffe; R Zakhour; W Zhang; G A Contreras; C S Bell; G Rodriguez; G Del Bianco; N Pérez; L J Benjamins; J R Murphy; G P Heresi; D Q Tran
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

3.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 4.  Host factors and early treatments to restrict paediatric HIV infection and early disease progression.

Authors:  Ketty Gianesin; Raffaella Petrara; Riccardo Freguja; Marisa Zanchetta; Carlo Giaquinto; Anita De Rossi
Journal:  J Virus Erad       Date:  2015-07-01

5.  Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.

Authors:  Xiuqiong Bi; Azumi Ishizaki; Lam Van Nguyen; Kazunori Matsuda; Hung Viet Pham; Chung Thi Thu Phan; Kiyohito Ogata; Thuy Thi Thanh Giang; Thuy Thi Bich Phung; Tuyen Thi Nguyen; Masaharu Tokoro; An Nhat Pham; Dung Thi Khanh Khu; Hiroshi Ichimura
Journal:  Int J Mol Sci       Date:  2016-08-02       Impact factor: 5.923

6.  Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection.

Authors:  Chun Li; Ilona Toth; Julian Schulze Zur Wiesch; Florencia Pereyra; Jennifer Rychert; Eric S Rosenberg; Jan van Lunzen; Mathias Lichterfeld; Xu G Yu
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

Review 7.  Immunity to HIV in Early Life.

Authors:  Maximilian Muenchhoff; Andrew J Prendergast; Philip Jeremy Renshaw Goulder
Journal:  Front Immunol       Date:  2014-08-12       Impact factor: 7.561

8.  Premature aging and immune senescence in HIV-infected children.

Authors:  Ketty Gianesin; Antoni Noguera-Julian; Marisa Zanchetta; Paola Del Bianco; Maria Raffaella Petrara; Riccardo Freguja; Osvalda Rampon; Clàudia Fortuny; Mireia Camós; Elena Mozzo; Carlo Giaquinto; Anita De Rossi
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

9.  Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.

Authors:  Andrew J Prendergast; Alexander J Szubert; Chipo Berejena; Godfrey Pimundu; Pietro Pala; Annie Shonhai; Victor Musiime; Mutsa Bwakura-Dangarembizi; Hannah Poulsom; Patricia Hunter; Philippa Musoke; Macklyn Kihembo; Paula Munderi; Diana M Gibb; Moira Spyer; A Sarah Walker; Nigel Klein
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

10.  Terminally differentiated memory T cells are increased in patients with common variable immunodeficiency and selective IgA deficiency.

Authors:  Jana Nechvatalova; Tomas Pavlik; Jiri Litzman; Marcela Vlkova
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.